A focus on our Therapy Areas
Britannia Pharmaceuticals Ltd. are dedicated to improving the lives of people with long-term neurological conditions, and providing important support for their families, caregivers, and medical teams.
We remain committed to making breakthroughs and providing ethical treatments and services that improve the lives of people living with Parkinson’s disease, schizophrenia, and provide support to everyone involved in their care.
Parkinson’s disease is a progressive neurodegenerative condition that occurs when some of the cells in the brain (neurons) stop working properly and are lost over time. People with Parkinson’s disease typically have movement-related (motor) problems like shaking, rigidity and difficulty walking.
Schizophrenia is a long-term severe mental health condition that causes a range of psychological symptoms. It is often described as a type of psychosis where people are not always able to distinguish thoughts and ideas from reality.
Our Nurse Service
Our dedicated nursing team, founded in 2008, works closely with healthcare professionals in the community to provide specialist care to patients with Parkinson’s disease and Schizophrenia.